Product guide · Restricted substance
Cartel Labs Omerta
Stimulant formula from Cartel Labz, powder. This guide sets out what the manufacturer states about the composition of Cartel Labs Omerta, what independent research says about its main ingredients, and the safety and regulatory points that apply. It contains substances that are not authorised as food or medicine in the EU. This guide is educational: it does not recommend use and gives no directions for use.
Back to the product- Named ingredients
- 8
- Amounts stated
- None
- Status
- Restricted substance
- Evidence summaries
- 11
Overview
Manufacturer informationIngredients & composition
Manufacturer information| Ingredient | Amount |
|---|---|
| N-Acetyl L-Tyrosine | Not stated |
| Citrulline malate | Not stated |
| Agmatine sulfate & AAKG | Not stated |
| Yohimbine HCl & synephrine | Not stated |
| Huperzine A | Not stated |
| Schisandra chinensis | Not stated |
| Vitamins D3, B12, c, magnesium, calcium | Not stated |
| Methylxanthine (Infinergy®) | Not stated |
The manufacturer does not state the amount of any ingredient. Without amounts, the research summarised in this guide cannot be related to this product's dose.
Not covered in detail in this guide: Schisandra chinensis.
Scientific background
Independent researchL-tyrosine
L-tyrosine is an amino acid that the body uses to make the neurotransmitters dopamine and noradrenaline. It is found in protein-rich foods; N-acetyl-L-tyrosine is a related form1.
L-citrulline and citrulline malate
L-citrulline is an amino acid that the body converts to arginine, a precursor of nitric oxide, which widens blood vessels. Citrulline malate combines citrulline with malic acid2.
Agmatine sulfate
Agmatine is formed in the body from the amino acid arginine and acts as a signalling molecule in the nervous system. It is sold as agmatine sulfate in sports and nootropic products.
L-arginine and AAKG
L-arginine is an amino acid used by the body to make nitric oxide. AAKG is arginine bound to alpha-ketoglutarate.
Yohimbine (yohimbe bark, rauwolscine)
Yohimbine is an alkaloid from the bark of the African tree Pausinystalia yohimbe. It blocks α2-adrenergic receptors, which increases noradrenaline release. Rauwolscine (alpha-yohimbine) is a closely related alkaloid.
Synephrine (bitter orange, Citrus aurantium)
p-Synephrine is the main protoalkaloid of bitter orange (Citrus aurantium). It is structurally related to adrenaline and is used in weight-loss and pre-workout products3.
Huperzine A
Huperzine A is an alkaloid from the club moss Huperzia serrata. It inhibits acetylcholinesterase, the enzyme that breaks down the neurotransmitter acetylcholine, and it has been used as a medicine for dementia in China4.
Magnesium
Magnesium is an essential mineral involved in hundreds of enzyme reactions, including energy metabolism, muscle contraction and nerve function5.
EFSA set adequate intakes of 350 mg a day for men and 300 mg a day for women, from all sources6. Supplements supply magnesium bound to different partners, such as oxide, citrate or glycinate. Labels should state the amount of elemental magnesium, which is lower than the weight of the compound.
Vitamin D3 (cholecalciferol)
Vitamin D is made in the skin in sunlight and is found in a few foods. It is needed for calcium absorption and bone health. EFSA set an adequate intake of 15 µg (600 IU) a day for adults7. 1 µg equals 40 IU.
Calcium
Calcium is the main mineral of bones and teeth and is needed for muscle and nerve function. EFSA based its adult reference values on calcium balance studies8.
Caffeine
Caffeine is a stimulant that blocks adenosine receptors in the brain, reducing perceived effort and fatigue. It is found in coffee, tea and energy drinks and is a common ingredient in pre-workout products9.
Dicaffeine malate (sold as Infinergy®) is caffeine bonded to malic acid. Its caffeine adds to the total caffeine in a product, but labels do not always state the caffeine equivalent.
Research evidence
Independent researchL-tyrosine
A review found that tyrosine may support cognitive performance in short-term stressful or cognitively demanding situations, when these neurotransmitters are temporarily depleted, but found no consistent effect on physical exercise performance1.
L-citrulline and citrulline malate
A review of human studies found that citrulline supplementation raises plasma arginine, and that several studies report improved exercise performance or recovery, but the results are inconsistent2.
Agmatine sulfate
Controlled human research on agmatine for exercise performance is very limited. Published human data are mostly small studies and a long-term case report10.
L-arginine and AAKG
A dose-response meta-analysis of randomised trials found that L-arginine lowered blood pressure in adults11. Evidence for improved exercise performance or "pump" is inconsistent; oral arginine is extensively broken down before reaching the circulation, which is why citrulline is often preferred2.
Yohimbine (yohimbe bark, rauwolscine)
A small trial in professional soccer players found reduced body fat with yohimbine but no change in body mass, muscle mass or performance12. Larger, independent trials are lacking.
Synephrine (bitter orange, Citrus aurantium)
A review of human clinical studies reported small increases in energy expenditure and modest weight loss with bitter orange extract or p-synephrine products over 6–12 weeks, many in combination with other ingredients3.
Huperzine A
A Cochrane review found some benefit on cognitive function in people with Alzheimer's disease, but only one study was of adequate quality and size, so there was inadequate evidence to recommend its use4. A Cochrane review in mild cognitive impairment found the evidence insufficient13.
There is no good evidence that huperzine A improves focus or performance in healthy people.
Magnesium
Authorised EU claims include that magnesium contributes to a reduction of tiredness and fatigue, to normal muscle function and to normal functioning of the nervous system, for foods that are a source of magnesium14.
For exercise performance, a review found that supplementation may help people with low magnesium status or older adults, but found no clear benefit in people who already have enough magnesium15.
Vitamin D3 (cholecalciferol)
Authorised EU claims include that vitamin D contributes to the maintenance of normal bones, muscle function and immune function14.
In the large VITAL trial, 2000 IU (50 µg) a day of vitamin D3 did not lower the incidence of invasive cancer or major cardiovascular events compared with placebo16. A meta-analysis found that vitamin D supplements did not prevent fractures or falls, or have clinically meaningful effects on bone density17.
Calcium
Authorised EU claims include that calcium is needed for the maintenance of normal bones and teeth and contributes to normal muscle function14.
Caffeine
The International Society of Sports Nutrition concludes that caffeine consistently improves exercise performance when consumed in doses of about 3–6 mg per kg of body mass, with benefits for muscular endurance, movement velocity, strength, sprinting, jumping and aerobic exercise9.
Evidence limitations
Independent researchThis product does not state all ingredient amounts, so the doses used in research cannot be compared with what one serving provides.
The studies summarised in this guide examined single ingredients. No published study has tested this product or this combination of ingredients.
L-tyrosine
Most studies are small and use single doses in laboratory settings1.
L-citrulline and citrulline malate
Studies differ in dose, form (citrulline or citrulline malate, often with an unverified ratio) and exercise test, and many are small. The mechanism behind any performance effect is not established2.
Agmatine sulfate
There are no large randomised trials showing a performance benefit from agmatine in healthy people. Claims of better "pump" or focus are not established.
L-arginine and AAKG
Studies vary in dose and population11.
Yohimbine (yohimbe bark, rauwolscine)
Evidence for fat loss or performance is limited to small studies. Supplement labels are often inaccurate: of 49 US yohimbine supplements tested, only 2 gave accurate information on both the quantity and the known adverse effects18.
Synephrine (bitter orange, Citrus aurantium)
Most studies are small, short and use multi-ingredient products, and longer studies are needed to establish efficacy and safety3.
Huperzine A
The trials are mostly small, of limited quality and in people with cognitive disease, so they do not apply to healthy users413.
Magnesium
Many studies on magnesium and health are observational or involve people with low magnesium status, so their findings do not show that extra magnesium helps people who are not deficient155.
Vitamin D3 (cholecalciferol)
Benefits are clearest for correcting deficiency. Trials in people with adequate vitamin D status show little benefit for bone, cancer or heart outcomes1617.
Calcium
Benefits beyond adequate intake are not established.
Caffeine
Responses vary widely between people, partly because of genetics and habitual caffeine use. Many studies use pure caffeine, so results do not automatically apply to multi-ingredient products9.
Safety & potential risks
- Not recommended for beginners or caffeine-sensitive users.
L-tyrosine
People taking MAO inhibitors or thyroid medication should not use tyrosine supplements without medical advice.
L-citrulline and citrulline malate
Citrulline is generally well tolerated in the doses studied. Digestive discomfort has been reported, and people taking blood-pressure or erectile-dysfunction medication should ask a doctor, because citrulline raises arginine and nitric oxide production2.
Agmatine sulfate
A case report described 5 years of high daily agmatine intake without detected adverse effects10. One case report cannot establish safety for the wider population.
L-arginine and AAKG
A risk assessment identified an observed safe level of 20 g a day19. Because it lowers blood pressure, people taking blood-pressure or erectile-dysfunction medication should ask a doctor first11.
Yohimbine (yohimbe bark, rauwolscine)
A review of poison-centre cases found that adverse events with yohimbine products had more serious outcomes than average exposures, including rapid heart rate, anxiety, high blood pressure and agitation20. People with heart conditions, high blood pressure, anxiety disorders or taking antidepressants should not use yohimbine.
Synephrine (bitter orange, Citrus aurantium)
The reviewed studies did not report serious adverse effects at the doses tested3, but combining synephrine with caffeine and other stimulants increases cardiovascular stress. People with high blood pressure, heart-rhythm disorders or taking stimulant or antidepressant medication should avoid it.
Huperzine A
As an acetylcholinesterase inhibitor, huperzine A can cause nausea, diarrhoea, sweating and a slow heart rate, and it may interact with medicines that affect acetylcholine or heart rate. Anyone taking medication or with heart, lung or digestive conditions should ask a doctor first.
Magnesium
The EU Scientific Committee on Food set a tolerable upper intake level of 250 mg a day for magnesium from supplements and fortified foods (readily dissociable salts and compounds such as magnesium oxide), based on mild, reversible diarrhoea as the most sensitive effect. Magnesium in normal food is not included21.
People with impaired kidney function can accumulate magnesium and should only supplement under medical advice. Magnesium can reduce the absorption of some antibiotics and osteoporosis medicines, so separate them by several hours or ask a pharmacist5.
Vitamin D3 (cholecalciferol)
EFSA set a tolerable upper intake level of 100 µg (4000 IU) a day for adults, based on persistent hypercalciuria (excess calcium in the urine) as an early sign of excess vitamin D22. Long-term intakes above this level can raise blood calcium and harm the kidneys. High-dose products should only be used on medical advice.
Calcium
The EU Scientific Committee on Food set an upper level of 2500 mg a day from all sources21.
Caffeine
EFSA concluded that single doses of up to 200 mg, and daily intakes of up to 400 mg from all sources, do not raise safety concerns for healthy adults. For pregnant and breastfeeding women, daily intakes up to 200 mg do not raise concerns for the foetus or infant23.
Higher intakes can cause anxiety, sleep disturbance, raised heart rate and blood pressure, and digestive upset. Combining several caffeine sources (coffee, energy drinks, pre-workouts) raises total intake239.
Regulatory status
Contains yohimbine. Isolated yohimbine is classified as a medicinal substance in several EU member states; its legal status depends on the country of sale.
L-tyrosine
Amino acids such as L-tyrosine are used in EU food supplements under national rules. No health claim is authorised14.
L-citrulline and citrulline malate
L-citrulline is used in EU food supplements under national rules. No health claim for citrulline is authorised in the EU14.
Agmatine sulfate
Agmatine sulfate is used in some EU food supplements under national rules. No health claim is authorised14. Whether a product needs novel food authorisation depends on its history of use24.
L-arginine and AAKG
No health claim for this ingredient is authorised in the EU14; botanical ingredients are sold under national food-supplement rules25.
Yohimbine (yohimbe bark, rauwolscine)
Yohimbine is a pharmacologically active substance. Its use in food is regulated under Regulation (EC) No 1925/2006 and national rules26, and several EU Member States treat it as a medicinal substance27.
Synephrine (bitter orange, Citrus aurantium)
Bitter orange extracts are used in EU food supplements under national rules, which differ between Member States25.
Huperzine A
Huperzine A is a pharmacologically active substance. Its status as a food ingredient is not harmonised in the EU, and some Member States treat it as a medicinal substance2724.
Magnesium
Magnesium is a permitted mineral in EU food supplements25. Authorised claims may only be used in their approved wording14.
Vitamin D3 (cholecalciferol)
It is a permitted nutrient in EU food supplements25; authorised claims may only be used in their approved wording and when the product is at least a source of the nutrient14.
Calcium
It is a permitted nutrient in EU food supplements25; authorised claims may only be used in their approved wording14.
Caffeine
Caffeine is permitted in EU foods and food supplements, subject to labelling rules. It is not on the World Anti-Doping Agency Prohibited List28.
Scientific references
- Jongkees BJ, Hommel B, Kühn S, et al. Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands: a review. J Psychiatr Res. 2015;70:50-57. PubMed 26424423
- Gonzalez AM, Trexler ET. Effects of citrulline supplementation on exercise performance in humans: a review of the current literature. J Strength Cond Res. 2020;34:1480-1495. PubMed 31977835
- Stohs SJ, Preuss HG, Shara M. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine. Int J Med Sci. 2012;9:527-538. PubMed 22991491
- Li J, Wu HM, Zhou RL, et al. Huperzine A for Alzheimer's disease. Cochrane Database Syst Rev. 2008;(2):CD005592. PubMed 18425924
- Fiorentini D, Cappadone C, Farruggia G, et al. Magnesium: biochemistry, nutrition, detection, and social impact of diseases linked to its deficiency. Nutrients. 2021;13:1136. PubMed 33808247
- EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific Opinion on Dietary Reference Values for magnesium. EFSA Journal. 2015;13(7):4186. DOI 10.2903/j.efsa.2015.4186
- EFSA NDA Panel. Dietary reference values for vitamin D. EFSA Journal. 2016;14:4547. DOI 10.2903/j.efsa.2016.4547
- EFSA NDA Panel. Scientific Opinion on Dietary Reference Values for calcium. EFSA Journal. 2015;13:4101. DOI 10.2903/j.efsa.2015.4101
- Guest NS, VanDusseldorp TA, Nelson MT, et al. International Society of Sports Nutrition position stand: caffeine and exercise performance. J Int Soc Sports Nutr. 2021;18:1. PubMed 33388079
- Gilad GM, Gilad VH. Long-term (5 years), high daily dosage of dietary agmatine: evidence of safety: a case report. J Med Food. 2014;17:1256-1259. PubMed 25247837
- Shiraseb F, Asbaghi O, Bagheri R, et al. Effect of L-arginine supplementation on blood pressure in adults: a systematic review and dose-response meta-analysis of randomized clinical trials. Adv Nutr. 2022;13:1226-1242. PubMed 34967840
- Ostojic SM. Yohimbine: the effects on body composition and exercise performance in soccer players. Res Sports Med. 2006;14:289-299. PubMed 17214405
- Yue J, Dong BR, Lin X, et al. Huperzine A for mild cognitive impairment. Cochrane Database Syst Rev. 2012;12:CD008827. PubMed 23235666
- Commission Regulation (EU) No 432/2012 establishing a list of permitted health claims made on foods. Official Journal of the European Union. Source
- Zhang Y, Xun P, Wang R, et al. Can magnesium enhance exercise performance? Nutrients. 2017;9:946. PubMed 28846654
- Manson JE, Cook NR, Lee IM, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380:33-44. PubMed 30415629
- Bolland MJ, Grey A, Avenell A. Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis. Lancet Diabetes Endocrinol. 2018;6:847-858. PubMed 30293909
- Cohen PA, Wang YH, Maller G, et al. Pharmaceutical quantities of yohimbine found in dietary supplements in the USA. Drug Test Anal. 2016;8:357-369. PubMed 26391406
- Shao A, Hathcock JN. Risk assessment for the amino acids taurine, L-glutamine and L-arginine. Regul Toxicol Pharmacol. 2008;50:376-399. PubMed 18325648
- Kearney T, Tu N, Haller C. Adverse drug events associated with yohimbine-containing products: a retrospective review of the California Poison Control System reported cases. Ann Pharmacother. 2010;44:1022-1029. PubMed 20442348
- Scientific Committee on Food / EFSA. Tolerable Upper Intake Levels for Vitamins and Minerals. European Food Safety Authority; 2006. Source
- EFSA NDA Panel. Scientific opinion on the tolerable upper intake level for vitamin D, including the derivation of a conversion factor for calcidiol monohydrate. EFSA Journal. 2023;21:8145. DOI 10.2903/j.efsa.2023.8145
- EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific Opinion on the safety of caffeine. EFSA Journal. 2015;13(5):4102. DOI 10.2903/j.efsa.2015.4102
- Regulation (EU) 2015/2283 on novel foods. Official Journal of the European Union. Source
- Directive 2002/46/EC on the approximation of the laws of the Member States relating to food supplements. Official Journal of the European Union. Source
- Regulation (EC) No 1925/2006 on the addition of vitamins and minerals and of certain other substances to foods. Official Journal of the European Union. Source
- Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union. Source
- World Anti-Doping Agency. The Prohibited List (current edition). Source
Sources checked against PubMed, Crossref or the official publisher on 2026-11-04. Manufacturer information is taken from the product's own data and has not been independently tested.

The product
Cartel Labs Omerta
€49,90 · Sold out